Headache, intracranial hypertension
However, the most important advantage is the very safe profile of BPC (the lethal dose (LD1) could be not achieved) (Seiwerth et al., 2018), emphasized in terms of its physiological role (assessed using in situ hybridization and immunostaining for BPC 157 in the human gastrointestinal mucosa, lung bronchial epithelium, the epidermal layer of the skin, and kidney glomeruli) (Seiwerth et al., 2018)
Dosage and administration The standard dose is 20 mcg injected subcutaneously once daily
The concentration refers to the tirzepatide content, not the B12
c-VLDL: colesterol unido a very low density lipoproteins (lipoprotenas de muy baja densidad)
10.1016/S2213-8587(23)00004-9 38 FerreiraG